(Q40682274)

22 September 2017

title

Class II transactivator-induced expression of HLA-DO(beta) in HeLa cells (English)

1 reference

22 September 2017

Khalil H

1

1 reference

22 September 2017

Deshaies F

2

1 reference

22 September 2017

Bellemare-Pelletier A

3

1 reference

22 September 2017

Brunet A

4

1 reference

22 September 2017

Faubert A

5

1 reference

22 September 2017

Azar GA

6

1 reference

22 September 2017

Thibodeau J

7

1 reference

22 September 2017

publication date

1 November 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

60

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

372-382

1 reference

Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Nonclassical MHC class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Mediation by HLA-DM of dissociation of peptides from HLA-DR

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

HLA-DO is an intracellular class II molecule with distinctive thymic expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Negative regulation by HLA-DO of MHC class II-restricted antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

21 January 2018

What to do with HLA-DO?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Regulation of MHC class II genes: lessons from a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Class II transactivator is required for maximal expression of HLA-DOB in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased ex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

A new technique for the assay of infectivity of human adenovirus 5 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

A statistical approach to determine monoclonality after limiting cell plating of a hybridoma clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Conserved structural features between HLA-DO beta and -DR beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Cellular distribution of a mixed MHC class II heterodimer between DRalpha and a chimeric DObeta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Recognition of sorting signals by clathrin adaptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DObeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

Assembly, transport, and function of MHC class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

HLA-DM: an in vivo facilitator of MHC class II peptide loading

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

A novel class II MHC molecule with unusual tissue distribution

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Multiple mechanisms regulate the expression of murine immune response genes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Altered antigen presentation in mice lacking H2-O

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

The function of the octamer-binding site in the DRA promoter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600504.X

7 January 2021

10.1034/J.1399-0039.2002.600504.X

Identifiers

DOI

1 reference

22 September 2017

1 reference